MedPath

Effects of over-the-counter lactic acid-containing vaginal douching products on the vaginal microbiota

Completed
Conditions
seksuele gezondheid
Bacteriële vaginose
disbalance of the vaginal microbiota
10004018
Registration Number
NL-OMON41739
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

Women of reproductive age between 18-36 years

Exclusion Criteria

Pregnancy or pregnancy wish
STI diagnosis
Age <18 and >36 years
Irregular menstruation
Use of antibiotics in the last 30 days
Known gynaecological pathology

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>For each participant, the vaginal microbiota composition before initiation of<br /><br>product use, during product use, and after cessation of product use will be<br /><br>assessed by next generation sequencing.<br /><br>For a general overview of the fluctuations in the composition of the vaginal<br /><br>microbiota over time, the sequencing results will be depicted in heatmaps.<br /><br>Furthermore, independent determinants for fluctuations in the composition of<br /><br>the vaginal microbiota will be determined by logistic regression analysis,<br /><br>linear discriminant analysis effect size, and principal component analysis.<br /><br>We will also track specific bacterial species that are associated with the<br /><br>normal vaginal microbiota and with BV, such as lactobacillus species,<br /><br>Gardenerella vaginalis, and Atopobium vaginae.<br /><br>We will use Nugent scoring and Amsel criteria to determine the BV status over<br /><br>time.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath